MX159807A - Procedimiento para preparar derivados de bencimidazol - Google Patents

Procedimiento para preparar derivados de bencimidazol

Info

Publication number
MX159807A
MX159807A MX206462A MX20646285A MX159807A MX 159807 A MX159807 A MX 159807A MX 206462 A MX206462 A MX 206462A MX 20646285 A MX20646285 A MX 20646285A MX 159807 A MX159807 A MX 159807A
Authority
MX
Mexico
Prior art keywords
benzmidazole
derivatives
preparing
procedure
preparing benzmidazole
Prior art date
Application number
MX206462A
Other languages
English (en)
Spanish (es)
Inventor
Susumu Okabe
Masaru Satoh
Tomio Yamakawa
Yutaka Nomura
Original Assignee
Nippon Chemiphar Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP59182400A external-priority patent/JPS6160660A/ja
Priority claimed from JP60061195A external-priority patent/JPH0764826B2/ja
Priority claimed from JP60061194A external-priority patent/JPH068283B2/ja
Application filed by Nippon Chemiphar Co filed Critical Nippon Chemiphar Co
Publication of MX159807A publication Critical patent/MX159807A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MX206462A 1984-08-31 1985-08-30 Procedimiento para preparar derivados de bencimidazol MX159807A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP59182400A JPS6160660A (ja) 1984-08-31 1984-08-31 ベンズイミダゾ−ル誘導体およびその製造法ならびにこれを含有する抗潰瘍剤
JP60061195A JPH0764826B2 (ja) 1985-03-26 1985-03-26 ベンズイミダゾール誘導体
JP60061194A JPH068283B2 (ja) 1985-03-26 1985-03-26 ベンズイミダゾ−ル誘導体およびその製造法ならびにこれを含有する抗潰瘍剤

Publications (1)

Publication Number Publication Date
MX159807A true MX159807A (es) 1989-08-31

Family

ID=27297422

Family Applications (1)

Application Number Title Priority Date Filing Date
MX206462A MX159807A (es) 1984-08-31 1985-08-30 Procedimiento para preparar derivados de bencimidazol

Country Status (14)

Country Link
KR (1) KR920004936B1 (fr)
AR (1) AR242195A1 (fr)
AU (3) AU4640985A (fr)
BE (1) BE903128A (fr)
BR (1) BR8504252A (fr)
CH (1) CH665417A5 (fr)
DE (1) DE3531487C2 (fr)
ES (1) ES8703142A1 (fr)
FR (1) FR2569691B1 (fr)
GB (1) GB2163747B (fr)
IT (1) IT1189601B (fr)
MX (1) MX159807A (fr)
NL (1) NL8502384A (fr)
SE (1) SE500669C2 (fr)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8417194D0 (en) * 1984-07-05 1984-08-08 Boots Co Plc Therapeutic agents
CA1341314C (fr) 1984-07-06 2001-11-06 David Cox Derives de benzimidazole, benzothiazole et benzoxazole
GB2161160B (en) * 1984-07-06 1989-05-24 Fisons Plc Heterocyclic sulphinyl compounds
AU5768886A (en) * 1985-05-24 1986-11-27 G.D. Searle & Co. 2-((1-h-benzimidazol-2-ylsulfinyl)methyl)benzenamines
US5869513A (en) * 1985-05-24 1999-02-09 G. D. Searle & Co. 2- (1H-benzimidazol-2-ylsulfinyl)methyl!benzenamines
US4824856A (en) * 1985-08-14 1989-04-25 Nippon Chemiphar Co., Ltd. Method of protecting gastrointestinal tract
WO1987001114A2 (fr) * 1985-08-21 1987-02-26 Byk Gulden Lomberg Chemische Fabrik Gmbh Nouvelles amines, leur procede de fabrication, leur utilisation, et medicaments les contenant
AR243167A1 (es) 1985-08-24 1993-07-30 Hoechst Ag Procedimiento para la preparacion de toluidinas sustituidas.
AU619444B2 (en) * 1986-06-02 1992-01-30 Nippon Chemiphar Co. Ltd. 2-(2-aminobenzylsulfinyl)- benzimidazole derivatives
EP0251536A1 (fr) * 1986-06-24 1988-01-07 FISONS plc Benzimidazoles, leur préparation, formulation et utilisation comme inhibiteurs de sécrétion d'acide gastrique
US4772619A (en) * 1986-07-17 1988-09-20 G. D. Searle & Co. [(1H-benzimidazol-2-ylsulfinyl)methyl]-2-pyridinamines
US4687775A (en) * 1986-07-17 1987-08-18 G. D. Searle & Co. 2-[(Imidazo[1,2-a]pyridinylmethyl)sulfinyl]-1H-benzimidazoles
US4721718A (en) * 1986-08-18 1988-01-26 G. D. Searle & Co. 2-[(imidazo[1,2-a]pyridin-3-ylmethyl)sulfinyl]-1H-benzimidazoles useful in the treatment and prevention of ulcers
DE3639926A1 (de) * 1986-11-22 1988-06-01 Hoechst Ag Substituierte thienoimidazoltoluidin-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer
IT1222412B (it) * 1987-07-31 1990-09-05 Chiesi Farma Spa Tiometil e sulfinil metil derivati ad azione antisecretiva acida gastrica,loro procedimento di preparazione e composizioni farmaceutiche che li contengono
JP2614756B2 (ja) * 1988-08-10 1997-05-28 日本ケミファ株式会社 イミダゾール誘導体およびその製造法ならびにこれを含有する抗潰瘍剤
JPH06298611A (ja) * 1993-04-16 1994-10-25 Nippon Chemiphar Co Ltd 抗菌剤
SE9301489D0 (sv) 1993-04-30 1993-04-30 Ab Astra Veterinary composition
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
SE9500422D0 (sv) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SE9500478D0 (sv) * 1995-02-09 1995-02-09 Astra Ab New pharmaceutical formulation and process
US5708017A (en) * 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
HRP960232A2 (en) * 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds
ATE262332T1 (de) * 1995-09-21 2004-04-15 Pharma Pass Ii Llc Lansoprazolhaltige arzneizusammensetzung und herstellungsverfahren
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
US6380222B2 (en) 1996-10-11 2002-04-30 Astrazeneca Ab Use of an H+, K+-atpase inhibitor in the treatment of nasal polyps
DE69827392T2 (de) 1997-07-25 2005-10-27 Altana Pharma Ag Protonenpumpenhemmer als kombinationstherapeutika mit antibakteriell wirkenden substanzen
SE9704870D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
AU772726B2 (en) 1998-08-12 2004-05-06 Takeda Gmbh Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles
WO2000027841A1 (fr) * 1998-11-06 2000-05-18 Dong-A Pharmaceutical Co., Ltd. Procede de preparation de derives de sulfure
TWI243672B (en) 1999-06-01 2005-11-21 Astrazeneca Ab New use of compounds as antibacterial agents
CA2376202C (fr) 1999-06-07 2008-11-18 Byk Gulden Lomberg Chemische Fabrik Gmbh Preparation et forme galenique comprenant un compose actif acido-labile
SE9903831D0 (sv) 1999-10-22 1999-10-22 Astra Ab Formulation of substituted benzimidazoles
SE0000774D0 (sv) 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
US6544556B1 (en) 2000-09-11 2003-04-08 Andrx Corporation Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
SE0101379D0 (sv) 2001-04-18 2001-04-18 Diabact Ab Komposition som hämmar utsöndring av magsyra
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
SE0102993D0 (sv) 2001-09-07 2001-09-07 Astrazeneca Ab New self emulsifying drug delivery system
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
ATE419840T1 (de) 2002-04-09 2009-01-15 Flamel Tech Sa Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen
ATE407674T1 (de) 2002-04-09 2008-09-15 Flamel Tech Sa Orale pharmazeutische formulierung in form einer wässrigen suspension von mikrokapseln zur modifizierten freisetzung von amoxicillin
SE0203065D0 (sv) 2002-10-16 2002-10-16 Diabact Ab Gastric acid secretion inhibiting composition
WO2004112756A1 (fr) 2003-06-26 2004-12-29 Isa Odidi Capsules contenant un inhibiteur de la pompe a protons comprenant des unites secondaires differemment structurees permettant une liberation retardee de l'ingredient actif
EP2184058B1 (fr) 2003-09-26 2012-02-08 ALZA Corporation Enrobage de médicaments à charge médicamenteuse élevée et procès de fabrication
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US20060024362A1 (en) 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US7981908B2 (en) 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
US7803817B2 (en) 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
EP2007360B1 (fr) 2006-04-03 2014-11-26 Isa Odidi Dispositif d'administration à libération commandée comprenant un enrobage organosol
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
CA2658804A1 (fr) 2006-07-25 2008-01-31 Vecta Ltd. Compositions et procedes d'inhibition de secretion d'acide gastrique utilisant des derives de petits acides dicarboxyliques combines a un ipp
CA2673665C (fr) 2006-12-22 2017-03-21 Ironwood Pharmaceuticals, Inc. Methodes et compositions de traitement de troubles oesophagiens
EA201100313A1 (ru) 2008-09-09 2011-10-31 Астразенека Аб Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом
CA2764963C (fr) 2009-06-25 2016-11-01 Astrazeneca Ab Procede pour le traitement d'un patient a risque de developer un ulcere associe a nsaid
EP2519229A2 (fr) 2009-12-29 2012-11-07 Novartis AG Nouvelle forme pharmaceutique destinée au traitement de troubles liés à l'acide gastrique
WO2011080502A2 (fr) 2009-12-29 2011-07-07 Orexo Ab Nouvelle forme pharmaceutique destinée au traitement de troubles liés à l'acide gastrique
WO2011080500A2 (fr) 2009-12-29 2011-07-07 Orexo Ab Nouvelle forme pharmaceutique destinée au traitement de troubles liés à l'acide gastrique
WO2012027331A1 (fr) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions et procédés pour traiter ou prévenir un syndrome métabolique et des maladies et troubles associés
EP2601947A1 (fr) 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Combinaison à dose fixe pour le traitement de maladies associées à Hélicobacter pylori
WO2013101897A2 (fr) 2011-12-28 2013-07-04 Pozen Inc. Compositions et procédés d'administration d'oméprazole plus acide acétylsalicylique améliorés
CN108057028A (zh) 2013-01-15 2018-05-22 铁木医药有限公司 片剂形式的肠溶包衣的胃内滞留口服剂型及其应用和药物组合物
EP2801565B1 (fr) * 2013-05-06 2015-07-22 King Saud University Composés destinés à être utilisés en tant qu'agent antiulcéreux et/ou agent anti-helicobacter pylori et leurs compositions pharmaceutiques
WO2016126625A1 (fr) 2015-02-03 2016-08-11 Ironwood Pharmaceuticals, Inc. Méthodes de traitement de troubles gastro-intestinaux supérieurs de gerd réfractaire à ppi

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CA1341314C (fr) * 1984-07-06 2001-11-06 David Cox Derives de benzimidazole, benzothiazole et benzoxazole

Also Published As

Publication number Publication date
KR920004936B1 (ko) 1992-06-22
DE3531487C2 (de) 1995-08-17
NL8502384A (nl) 1986-03-17
FR2569691A1 (fr) 1986-03-07
DE3531487A1 (de) 1986-03-13
AU647978B2 (en) 1994-03-31
SE500669C2 (sv) 1994-08-08
GB2163747B (en) 1989-02-08
FR2569691B1 (fr) 1989-08-04
GB2163747A (en) 1986-03-05
SE8504048D0 (sv) 1985-08-30
AU4640985A (en) 1986-03-06
KR860001793A (ko) 1986-03-22
ES546445A0 (es) 1986-11-16
SE8504048L (sv) 1986-03-01
AU4127189A (en) 1989-12-21
BR8504252A (pt) 1986-06-17
BE903128A (fr) 1985-12-16
AR242195A1 (es) 1993-03-31
IT1189601B (it) 1988-02-04
CH665417A5 (fr) 1988-05-13
ES8703142A1 (es) 1986-11-16
GB8521493D0 (en) 1985-10-02
AU2975092A (en) 1993-01-28
IT8567743A0 (it) 1985-08-30

Similar Documents

Publication Publication Date Title
MX159807A (es) Procedimiento para preparar derivados de bencimidazol
ES548922A0 (es) Procedimiento para preparar nuevos derivados de aminotetra- lina
ES544204A0 (es) Procedimiento para preparar dialcoxipiridinas
ES542976A0 (es) Procedimiento para preparar pirrolo-bencimidazoles
ES540464A0 (es) Procedimiento para preparar derivados de pleuromutilina
ES550730A0 (es) Procedimiento para preparar poliesterpolioles
ES557522A0 (es) Procedimiento para preparar derivados de cinolina
ES557693A0 (es) Procedimiento para preparar derivados de imidazolilalquilguanidina
ES555561A0 (es) Procedimiento para preparar celalosporinas
MX159654A (es) Procedimiento para preparar derivados de hidroxi-4-2h-1-benzotiopiran-2-onas
ES546847A0 (es) Procedimiento para preparar derivados de carbamoilimidazol fungicidas
ES552955A0 (es) Procedimiento para preparar derivados de bencimidazol substituidos
ES549975A0 (es) Procedimiento para preparar n-formil-&-aspartil fenilalanina
ES550961A0 (es) Procedimiento para preparar derivados azolilalquilicos
MX160612A (es) Procedimiento para preparar 3-carbonil-1-aminoalquil-1h-indoles
ES548237A0 (es) Procedimiento para preparar n6-bicicloadenosinas
ES543985A0 (es) Procedimiento para preparar derivados de butiramida
ES544622A0 (es) Procedimiento para preparar l-fenilalamina
ES542469A0 (es) Procedimiento de preparar derivados iminotiazolidinicos
ES545599A0 (es) Procedimiento para la obtencion de derivados de ciclohexeno-na
ES544074A0 (es) Procedimiento para preparar naftoxacinas
ES549076A0 (es) Procedimiento para preparar derivados de fenilpiperazina
MX162329A (es) Procedimiento para preparar acilhidrazonas sulfeniladas
MX159907A (es) Procedimiento para preparar cloro-o-nitroanilinas
ES557069A0 (es) Procedimiento para preparar derivados de benzazol